Initia participated in the ABGREF Congress in Brazil, where clinical evidence, physician engagement, and market exposure came together in a focused women’s health event.

Over the past year, physicians from ABGREF have been important clinical partners in evaluating MORENOVA for stress urinary incontinence and female sexual dysfunction, contributing to the continued development of clinical knowledge around Low-Intensity Extracorporeal Shockwave Therapy.

Clinical Evidence Presented at the Congress

During the congress, Dr. Vanessa Munhoz Bitelman presented findings from the clinical evaluation of MORENOVA, providing an opportunity to share the study results with physicians and healthcare professionals attending the event.

The presentation highlighted the connection between ongoing clinical investigation and the growing interest in shockwave-based solutions for women’s health.

Connecting Clinical Validation and Market Engagement

Alongside the scientific presentation, the Initia booth generated strong interest and meaningful conversations with healthcare professionals, offering visitors hands-on exposure to the MORENOVA platform and its technology.

The event reinforced the value of combining clinical collaboration with direct physician engagement, supporting both professional awareness and continued market development in Brazil.

Initia thanks the ABGREF team, the participating physicians, and everyone who visited the booth and joined the conversation. We look forward to continuing this collaboration and supporting further clinical engagement in women’s health.